Filter News

Recent News

10 November 2020

MPE Properties Ltd. redeems loan notes in full

In March 2015, MPE Properties Ltd raised £1,050,000 through the issue of medium term notes under the terms of a loan note programme arranged by LGB. Read more
9 November 2020

FTSE100 rockets as investors see light at the end of the lockdown tunnel

Andrew Boyle, CEO of LGB & Co., commented in a ProActive Investors piece on the Pfizer vaccine announcement.    Read more
3 November 2020

Pre-election IPO rush set to slow in Europe, Asia

Ivan Sedgwick, Investment Director at LGB & Co., contributed to an article on Bloomberg on the impact on IPOs in the run up to the US presidential election. Read more
27 October 2020

LGB helps fund microbiome therapies for the skin

SkinBioTherapeutics plc, a company we have grown close to in the last 12 months, has announced that it has raised £4 million (before expenses) at 16p. Read more
27 October 2020

£10 million reverse enquiry completed under the Simply Asset Finance MTN Programme

We are pleased to announce the successful completion of a £10 million investment from a substantial family office under the Simply Asset Finance MTN Programme. Read more
16 October 2020

Winter nerves in boardrooms could trigger second round of fundraisings

LGB & Co. CEO Andrew Boyle contributed to an article in The Times on the possibility of a new round of fundraising for UK-listed companies. Read more
12 October 2020

Scancell announces a further £30m investment by funds managed by Redmile, LLC

Scancell Holdings plc, one of our longstanding corporate clients, has announced< Read more
5 October 2020

London’s ‘enfant terrible’ Aim market comes of age as FTSE 100 stutters

Ivan Sedgwick, Investments Director at LGB & Co, contributed to an article in The Times on the AIM market. Read more
29 September 2020

LGB Forms an Alliance with Smith Square Partners

We are excited to announce that LGB has entered in to an alliance with Smith Square Partners ( Read more
7 September 2020

Back British biotech by improving the clinical trials process

Andrew Boyle, CEO of LGB & Co. Limited, wrote an article for Pharmiweb on how to improve the British biotech sector. Read more
1 September 2020

Is it safe to get back in the water? SME credit investments in the post-Covid world

Please join us to hear from our expert panel on how investors are viewing the market and assessing SME risk and resilience over the next 6 months and beyond. Read more